Protecting infants against respiratory syncytial virus this winter — ECDC issues advice
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of…
World marks cervical cancer elimination day as countries accelerate action
Today marks the first World Cervical Cancer Elimination Day – mandated by the World Health Assembly – a historic milestone in global efforts to end a preventable cancer. This day…
Catch-up Immunization Campaign Launched in the Gaza Strip
UNICEF, UNRWA, WHO and partners, in collaboration with the Ministry of Health, are launching an integrated catch-up campaign for routine immunization, nutrition, and growth monitoring in the Gaza Strip to…
WHO: Recommendations announced for influenza vaccine composition for the 2026 southern hemisphere influenza season
The World Health Organization (WHO) today announced its recommendations for the viral composition of influenza vaccines for use in the 2026 influenza season in the southern hemisphere. The announcement was…
Americans don’t think bird flu is a threat
In an editorial in the American Journal of Public Health, a team led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) say public…
Researchers use biophysics to design new vaccines against RSV, HMPV and related respiratory viruses
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe…
Bird flu during pregnancy: women died in 90% of cases
The vast majority of women who contract bird flu during pregnancy and their unborn baby will die from the virus, according to a new study. And the findings stress the…
New hope in the fight against Hepatitis C: Broadly effective innovative vaccine design
Globally, approximately 58 million people are chronically infected with HCV, resulting in 290,000 annual deaths due to complications such as liver cirrhosis and liver cancer. Although modern antiviral treatments achieve…
Bacterial vaccine shows promise as cancer immunotherapy
Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s…
An AI-powered pipeline for personalized cancer vaccines
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses…